COMPASS™ Registry
Outcomes Data Collection (Spinal Fusion)
RegistryEnrollment Completed
Key Facts
Indication
Outcomes Data Collection (Spinal Fusion)
Phase
Registry
Status
Enrollment Completed
Company
About Carlsmed
Carlsmed's mission is to improve patient outcomes and decrease the cost of healthcare in spine surgery by shifting from standard implants to a fully personalized approach. The company has achieved significant commercial traction with its FDA-cleared aprevo® platform, reporting $50.5 million in revenue for FY 2025, representing 86% year-over-year growth. Its strategy centers on expanding its personalized implant portfolio, generating robust clinical evidence, and leveraging its integrated digital platform to drive adoption in the large and growing spine surgery market.
View full company profile